Presented at European Association of Dermato Oncology (EADO) 2018

Collaborator: Pierre Fabre

Authors: Basset Seguin N, Malvehy J, Ulianov L, Condomines M, Beauchamp R, Dos Santos R

While organ transplants greatly improve patients’ quality of life, transplant patients must nonetheless take immunosuppressive drugs to prevent organ rejection. Thus, new risks emerge, including a higher chance of developing non-melanoma skin cancer (NMSC). The objectives of the study were to describe characteristics of patients with and without skin lesions and to better understand the skin monitoring after organ transplant.

Access to the poster